OVN 0.00% 2.0¢ oventus medical limited

Ann: Quarterly Business Review & Appendix 4C, page-4

  1. 33,610 Posts.
    lightbulb Created with Sketch. 1770
    yes pretty much as we predicted re costs and receipts.
    , the bulk of that $1 m pa goes to the CEO although based on the blurb in the announcement it looks like he is not drawing much of a salary currently and there are going to be cuts in remuneration going forward , however still going to be some serious questions asked by current and prospective shareholders when the company goes to the market for a CR given only a 5% rise in receipts compared to the previous quarter ,
    If the company wants to get the CR at close to VWAP over the last month , it better have a definitive strategy in increasing the topline by at least 20% quarter on quarter as poster Moossey projected months ago
 
watchlist Created with Sketch. Add OVN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.